Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03283696 |
| Title | A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Miami School of Medicine | Miami | Florida | 33136 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Universitätsklinikum Essen | Essen | Nordrhein-Westfalen | 45122 | Germany | Details | |
| HELIOS Klinikum Berlin-Buch | Berlin | 13125 | Germany | Details | ||
| Istituto Nazionale dei Tumori | Milano | Lombardie | 20133 | Italy | Details | |
| Università degli Studi di Catania - Azienda Policlinico | Catania | 95123 | Italy | Details |